Delivery Order SPE2DB22D2006-SPE2DB25FW3WH
- Not listed
- The Defense Logistics Agency awarded a $2,092.43 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This competitively awarded, firm fixed-price delivery order is set to be completed by June 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement typical of routine medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,056.72 to AmerisourceBergen Drug Corp for Amoxicillin-Clavulanate 875-125 mg tablets (100 count) on August 14, 2025, with a completion date of August 15, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,462.61 to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20 on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,981.11 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets in quantities of 20. This firm fixed-price contract, which must be completed by July 30, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for AMOXICILLIN-CLAVULANATE 875-125 mg tablets (20-count packages) under a firm fixed-price contract valued at $1,624.54. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Amoxicillin-Clavulanate 400-57 mg/5 mL suspension in 100 mL quantities, with a ceiling value of $2,030.54. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is set for ultimate completion on August 28, 2025, reflecting the expedited nature typical of pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for amoxicillin-clavulanate suspension (400-57 mg/5 ml, 100 ml) under a firm fixed-price contract with a ceiling value of $1,170.97. The award, issued on September 19, 2025, is a non-set-aside competitive procurement with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amoxicillin-Clavulanate 400-57 mg/5 mL suspension (100 mL) with a ceiling value of $3,441.06. The contract is non-competitive, firm fixed price delivery order with an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor that...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,333.19 firm fixed-price contract is for the supply of Amoxicillin-Clavulanate 1,000-62.5 mg tablets to support military healthcare programs. The contract has an ultimate completion date of December 12, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,260.98 to AmerisourceBergen Drug Corp for the supply of Amoxicillin 400 mg/5 ml suspension in 75 ml quantities. This firm fixed-price, non-set-aside delivery order was awarded on September 13, 2025, with an ultimate completion date of September 15, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3WHDelivery Order
The Defense Logistics Agency awarded a $2,107.38 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Amoxicillin-Clavulanate 875-125 mg tablets (20 units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the company's role as a critical pharmaceutical distributor for federal medical procurement needs. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive contract vehicle enables AmerisourceBergen to supply a wide range of pharmaceutical products, medical supplies, and vaccines to support military healthcare systems globally. As a prime vendor under this framework, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, providing both brand-name and generic medications across numerous therapeutic domains to sustain military medical operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/26/25 |